<DOC>
	<DOCNO>NCT00039364</DOCNO>
	<brief_summary>RATIONALE : Imatinib mesylate may interfere growth tumor cell slow growth tumor . PURPOSE : Phase II trial study effectiveness imatinib mesylate treat patient glioma .</brief_summary>
	<brief_title>Imatinib Mesylate Treating Patients With Gliomas</brief_title>
	<detailed_description>OBJECTIVES : - Determine therapeutic activity imatinib mesylate ( term objective response progression-free survival 6 month ) patient gliomas . - Determine safety drug patient . - Determine pharmacokinetics drug patient . OUTLINE : This multicenter study . Patients stratify accord glioma ( glioblastoma multiforme v anaplastic oligodendroglioma mixed oligoastrocytoma v anaplastic astrocytoma recurrent low-grade astrocytoma ) . Patients receive oral imatinib mesylate twice daily . Treatment repeat every 4 week 9 course absence disease progression unacceptable toxicity . Patients follow every 2 month 6 month every 3 month thereafter . PROJECTED ACCRUAL : A total 77 patient ( 29 patient glioblastoma multiforme , 24 patient anaplastic oligodendroglioma mixed oligoastrocytoma , 24 patient anaplastic astrocytoma recurrent low-grade astrocytoma ) accrue study .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm glioblastoma multiforme Recurrent disease CT scan MRI No prior chemotherapy OR No 1 prior chemotherapy regimen adjuvant set recurrent disease OR Histologically cytologically confirm anaplastic oligodendroglioma , mixed oligoastrocytoma , anaplastic astrocytoma , recurrent lowgrade astrocytoma Failed prior radiotherapy No 1 prior chemotherapy regimen Failed adjuvant chemotherapy OR Failed firstline chemotherapy At least 1 bidimensionally measurable target lesion At least 2 cm contrastenhanced CT scan MRI PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Neutrophil count least 2,000/mm^3 Platelet count least 100,000/mm^3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) AST ALT great 2.5 time ULN Alkaline phosphatase great 2.5 time ULN Renal : Creatinine le 1.7 mg/dL Cardiovascular : Cardiac function normal No ischemic heart disease within past 6 month Normal 12lead ECG Other : No prior concurrent malignancy except conebiopsied carcinoma cervix adequately treat basal cell squamous cell skin cancer No unstable systemic disease No active uncontrolled infection No psychological , familial , sociological , geographical condition would preclude study compliance Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 3 month study PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent anticancer biologic agent No concurrent cytokine ( e.g. , filgrastim [ GCSF ] sargramostim [ GMCSF ] ) Chemotherapy : See Disease Characteristics At least 4 week since prior chemotherapy ( 6 week nitrosourea ) No concurrent chemotherapy Endocrine therapy : Must stable decrease dose corticosteroid least 2 week Radiotherapy : See Disease Characteristics At least 3 month since prior brain irradiation No prior highdose radiotherapy ( 65 Gy ) , stereotactic radiosurgery , internal radiotherapy unless recurrence histologically confirm No concurrent radiotherapy Surgery : Prior surgery primary brain tumor within past 3 month allow provide one follow condition present : Postoperative imaging within 72 hour surgery show clearly limited target lesion least 2 cm Postoperative followup show progressive measurable target lesion A second measurable target lesion present outside surgical area Other : No concurrent warfarin anticoagulants No concurrent anticancer agents No concurrent investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
</DOC>